COVID Vaccine Developments: TFF Pharmaceuticals and Dr. Harlan Weisman at Emory University Drive Innovations
Friday, 13 September 2024, 16:53
COVID vaccine developments are crucial in combating respiratory illnesses like influenza and COVID. TFF Pharmaceuticals, led by Dr. Harlan Weisman and in collaboration with Emory University, is spearheading the advancement of inhaled mRNA treatments.
This innovative program utilizes Thin Film Freezing (TFF) technology to create a dry powder inhaler that may enhance the efficacy and accessibility of vaccines. The FastX Program reflects a commitment to developing rapid responses to urgent health threats.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.